Petrelintide
unknown (auto-discovered: incretin-obesity, muscle-preservation)
Also known as: RO7895515, ZP8396
Classification
Peptide
Regulatory Status
investigational; registered trials: NCT07843498, NCT07843472, NCT07843485 (PHASE3)
Unofficial source
Sources
3
Review
pending review
Overview
Unknown — Petrelintide was found by open discovery on 2026-10-26 and has not been researched yet.
Evidence and limitations
Known
n/a
Unknown
- Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.
Study details: trial conditions, not guidance
These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.
Doses found
Doses as found in each source, with its grade. What was found, not a direction.
Studies, trials and professional sources
n/a
Reddit, Facebook, Instagram, forums and blogs
n/a
Claims and grades
- Not gradedPetrelintide is being studied in a registered trial: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity (NCT07843498; PHASE3; RECRUITING; sponsor Hoffmann-La Roche; intervention "Petrelintide" (COMBINATION_PRODUCT)).
- Not gradedPetrelintide is being studied in a registered trial: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease (NCT07843472; PHASE3; RECRUITING; sponsor Hoffmann-La Roche; intervention "Petrelintide" (COMBINATION_PRODUCT)).
- Not gradedPetrelintide is being studied in a registered trial: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (NCT07843485; PHASE3; RECRUITING; sponsor Hoffmann-La Roche; intervention "Petrelintide" (COMBINATION_PRODUCT)).
Sources (3)
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-09-28
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-09-28
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (opens in a new tab) · ClinicalTrials.gov · trial-registry · 2026-09-28
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw